| 2026-05-15 |
详情>>
内部人交易：
Rondoni John股份减少2641.00股
|
| 2026-05-04 |
详情>>
股本变动：
变动后总股本2881.32万股
|
| 2026-05-04 |
详情>>
业绩披露：
2026年一季报每股收益-0.39美元,归母净利润-1129.4万美元,同比去年增长-477.47%
|
| 2026-05-04 |
财报披露：
美东时间 2026-05-04 盘后发布财报
|
| 2026-03-20 |
股东大会：
将于2026-04-30召开股东大会
会议内容 ▼▲
- 1.Elect Gary L. Ellis, Georgia Melenikiotou, and Dana G. Mead, Jr. as Class II directors to hold office until the Company’s annual meeting of stockholders to be held in 2029 and until their respective successors have been duly elected and qualified
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2026
3.Approve, on an advisory (non-binding) basis, of the compensation of our named executive officers
4.Approve, on an advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of our named executive officers
5.Approve an amendment to our Seventh Amended and Restated Certificate of Incorporation to phase out the classified Board structure and provide for the annual election of all directors beginning with our 2029 annual meeting of stockholders
6.Approve an amendment and restatement of the Inspire Medical Systems, Inc. 2018 Incentive Award Plan
7.Approve an adjournment of the Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes at the time of the Annual Meeting to approve Proposal No. 5 and/or Proposal No. 6
|
| 2026-02-27 |
复牌提示：
2026-02-26 14:39:31 停牌，复牌日期 2026-02-26 14:44:43
|
| 2026-02-13 |
详情>>
业绩披露：
2023年年报每股收益-0.72美元,归母净利润-2115.3万美元,同比去年增长52.87%
|
| 2026-02-13 |
详情>>
业绩披露：
2025年年报每股收益4.95美元,归母净利润1.45亿美元,同比去年增长171.77%
|
| 2025-11-03 |
详情>>
业绩披露：
2025年三季报(累计)每股收益0.32美元,归母净利润933.20万美元,同比去年增长-48.96%
|
| 2025-08-04 |
详情>>
业绩披露：
2025年中报每股收益-0.02美元,归母净利润-60万美元,同比去年增长-183.02%
|
| 2025-05-05 |
详情>>
业绩披露：
2025年一季报每股收益0.10美元,归母净利润299.20万美元,同比去年增长129.91%
|
| 2025-03-18 |
股东大会：
将于2025-05-01召开股东大会
会议内容 ▼▲
- 1.Elect Cynthia B. Burks, Timothy P. Herbert, and Shawn T McCormick as Class I directors to hold office until the Company’s annual meeting of stockholders to be held in 2028 and until their respective successors have been duly elected and qualified
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2025
3.Approve, on an advisory (non-binding) basis, of the compensation of our named executive officers
|
| 2025-02-10 |
详情>>
业绩披露：
2022年年报每股收益-1.6美元,归母净利润-4488.1万美元,同比去年增长-6.75%
|
| 2025-02-10 |
详情>>
业绩披露：
2024年年报每股收益1.80美元,归母净利润5350.90万美元,同比去年增长352.96%
|
| 2024-11-04 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.61美元,归母净利润1828.50万美元,同比去年增长150.91%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益-0.01美元,归母净利润-21.2万美元,同比去年增长99.23%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-0.34美元,归母净利润-1000.5万美元,同比去年增长35.13%
|
| 2024-03-19 |
股东大会：
将于2024-05-02召开股东大会
会议内容 ▼▲
- 1.Elect Shelley G. Broader, Myriam J. Curet, M.D., and Casey M. Tansey as Class III directors to hold office until the Company’s annual meeting of stockholders to be held in 2027 and until their respective successors have been duly elected and qualified
2.Ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2024
3.Approve, on an advisory (non-binding) basis, of the compensation of our named executive officers
|
| 2023-03-17 |
股东大会：
将于2023-04-27召开股东大会
会议内容 ▼▲
- 1.To elect Cynthia B. Burks, Gary L. Ellis, Georgia Garinois-Melenikiotou, and Dana G. Mead, Jr. as Class II directors to hold office until the Company’s annual meeting of stockholders to be held in 2026 and until their respective successors have been duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2023;
3.To approve, on an advisory (non-binding) basis, the compensation of our named executive officers;
4.To transact such other business as may properly come before the Annual Meeting or any continuation, postponement or adjournment thereof.
|
| 2022-03-16 |
股东大会：
将于2022-04-28召开股东大会
会议内容 ▼▲
- 1.to elect Shelley G. Broader, Timothy P. Herbert, and Shawn T McCormick as Class I directors to hold office until the Company’s annual meeting of stockholders to be held in 2025 and until their respective successors have been duly elected and qualified;
2.to ratify, in a non-binding vote, the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2022;
3.to approve, on an advisory (non-binding) basis, the compensation of our named executive officers;
4.to transact such other business as may properly come before the Annual Meeting or any continuation, postponement or adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-16 |
股东大会：
将于2021-04-29召开股东大会
会议内容 ▼▲
- 1.to elect Marilyn Carlson Nelson, Jerry C. Griffin, M.D., and Casey M. Tansey as Class III directors to hold office until the Company’s annual meeting of stockholders to be held in 2024 and until their respective successors have been duly elected and qualified;
2.to ratify, in a non-binding vote, the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2021;
3.to approve, on an advisory (non-binding) basis, the compensation of our named executive officers;
4.to transact such other business as may properly come before the Annual Meeting or any continuation, postponement or adjournment thereof.
|
| 2020-03-16 |
股东大会：
将于2020-04-30召开股东大会
会议内容 ▼▲
- 1.to elect Gary L. Ellis, Mudit K. Jain, Ph.D., and Dana G. Mead, Jr. as Class II directors to hold office until the Company’s annual meeting of stockholders to be held in 2023 and until their respective successors have been duly elected and qualified;
2.to ratify, in a non-binding vote, the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2020;
3.to approve, on an advisory (non-binding) basis, the compensation of our named executive officers;
4.to approve, on an advisory (non-binding) basis, the frequency of future advisory votes on the compensation of our named executive officers;
5.to transact such other business as may properly come before the Annual Meeting or any continuation, postponement or adjournment thereof.
|
| 2019-03-20 |
股东大会：
将于2019-05-02召开股东大会
会议内容 ▼▲
- 1.to elect Timothy Herbert, Chau Khuong and Shawn T McCormick as Class I directors to hold office until the Company’s annual meeting of stockholders to be held in 2022 and until their respective successors have been duly elected and qualified;
2.to ratify, in a non-binding vote, the appointment of Ernst & Young LLP as our independent registered public accounting firm for 2019;
3.to transact such other business as may properly come before the Annual Meeting or any continuation, postponement or adjournment thereof.
|